The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation.
The guanine nucleotide-exchange factor Vav is a regulator of antigen-mediated cytoskeletal reorganization required for receptor clustering, proliferation and thymic selection. Moreover, Vav has been identified as a major substrate in the CD28 signal transduction pathway and overexpression of Vav enh...
Main Authors: | Penninger, J, Fischer, K, Sasaki, T, Kozieradzki, I, Le, J, Tedford, K, Bachmaier, K, Ohashi, P, Bachmann, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1999
|
Similar Items
-
The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens.
by: Bachmann, M, et al.
Published: (1999) -
Vav regulates peptide-specific apoptosis in thymocytes.
by: Kong, Y, et al.
Published: (1998) -
VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles
by: Myriam Cuadrado, et al.
Published: (2021-09-01) -
Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models
by: Batel Shalom, et al.
Published: (2023-04-01) -
Differential Requirement of Vav Proteins for Btk-dependent and –Independent Signaling During B Cell Development
by: Annika C. Betzler, et al.
Published: (2022-02-01)